Targeting the microtubule cytoskeleton to promote cavernous nerve regeneration and erectile function after injury
Project Number5R01DK136889-02
Contact PI/Project LeaderDAVIES, KELVIN P Other PIs
Awardee OrganizationALBERT EINSTEIN COLLEGE OF MEDICINE
Description
Abstract Text
Abstract
We recently published in vitro studies identifying Fidgetin-like 2 (FL2) as a novel regulator of microtubule
dynamics, with an inhibitory effect on axonal growth and nerve regeneration [1]. Since FL2-depletion had axonal
growth-promoting effects in vitro, we tested whether FL2 could be targeted to promote nerve regeneration in a
rodent model of cavernous nerve (CN) injury. The CNs are parasympathetic nerves that regulate blood flow to
the penis and are commonly damaged during the surgical procedures of radical prostatectomy (RP), resulting in
erectile dysfunction (ED). Remarkably, in these rodent models, FL2-depletion at the site and time of CN injury
led to accelerated visible nerve regeneration, accompanied by improved erectile function outcomes. However,
axonal outgrowth is only one component in the complex process of regenerating functional peripheral nerves,
which also involves recruitment and activity of multiple accessory cell-types, such as Schwann cells, immune
cells, and endothelial cells [2, 3]. In other published studies, we have demonstrated that FL2 can regulate motility
and migration of several cell types [4]. Therefore, we hypothesize that the mechanism by which FL2-
depletion promotes CN regeneration and improves erectile function outcomes following injury is multi-
faceted, involving accelerated migration of key cell types to the site of injury, in addition to enhancing
axonal growth. We will test this hypothesis using both in vitro and in vivo models and confirm that the
mechanisms of CN repair function in both young and older animals (more appropriate to the age at which men
undergo RP).
We will test our hypothesis through two Specific Aims. In Aim 1, we will determine if accelerated nerve
regeneration by FL2-depletion is associated with increased migration of Schwann cells, immune cells, and
endothelial cells to the site of CN injury and if aging affects the recruitment of these accessory cell-types. In Aim
2 we will determine the ability of targeted FL2-depletion to promote CN-regeneration, preserve penile
architecture and recover erectile function in rat models of RP.
Our research will lead to greater understanding of the underlying mechanisms by which FL2-depletion promotes
CN repair and recovery of erectile function after RP, and if aging affects these mechanisms. By understanding
these mechanisms, we will potentially identify novel therapeutic strategies not only to treat, but also to prevent,
ED following RP.
Public Health Relevance Statement
Narrative
Our recently published studies have identified the protein Fidgetin-like 2 (FL2) as a novel regulator of microtubule
dynamics. With targeted FL2-depletion, there is accelerated nerve regeneration and improved erectile function
outcomes in animal models of radical prostatectomy (RP). The present proposal expands these studies by
investigating mechanisms by which FL2-depletion enhances nerve regeneration through the recruitment of cells
involved in nerve repair and determining the extent to which targeted FL2-depletion improves erectile function
outcomes in rat models of nerve injury.
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
847
DUNS Number
081266487
UEI
H6N1ZF5HJ2G3
Project Start Date
01-September-2023
Project End Date
30-June-2028
Budget Start Date
01-July-2024
Budget End Date
30-June-2025
Project Funding Information for 2024
Total Funding
$619,843
Direct Costs
$392,890
Indirect Costs
$226,953
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Diabetes and Digestive and Kidney Diseases
$619,843
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01DK136889-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01DK136889-02
Patents
No Patents information available for 5R01DK136889-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01DK136889-02
Clinical Studies
No Clinical Studies information available for 5R01DK136889-02
News and More
Related News Releases
No news release information available for 5R01DK136889-02
History
No Historical information available for 5R01DK136889-02
Similar Projects
No Similar Projects information available for 5R01DK136889-02